Point-of-Care Glucose Testing Market by Product, Mode of Purchase, End-User

List of Tables

The Point-of-Care Glucose Testing Market was valued at USD 6.70 billion in 2023, expected to reach USD 7.20 billion in 2024, and is projected to grow at a CAGR of 7.54%, to USD 11.15 billion by 2030.

The scope of Point-of-Care Glucose Testing (POCT) encompasses its critical role in providing immediate glucose level readings, enabling timely management of diabetes in various settings such as hospitals, clinics, and home environments. The necessity of POCT arises from the growing prevalence of diabetes and the need for regular monitoring to prevent complications. Its applications span across self-monitoring for individuals with diabetes, diabetes management in clinical and emergency settings, and during surgeries or critical care where glucose control is vital. The end-use scope largely includes hospitals, clinics, and home care, with an increasing trend toward home testing due to convenience and rising patient empowerment in managing health.

KEY MARKET STATISTICS
Base Year [2023]	USD 6.70 billion
Estimated Year [2024]	USD 7.20 billion
Forecast Year [2030]	USD 11.15 billion
CAGR (%)	7.54%

Key growth influencers in the market include the rising incidence of diabetes globally, technological advancements in testing devices such as non-invasive monitors, and increased healthcare spending. Opportunities mainly lie in emerging markets with growing healthcare infrastructure and a rising diabetic population, where affordable and easy-to-use POCT devices can make a significant impact. Recommendations for capturing these opportunities include leveraging technological innovations for product differentiation, focusing on user-friendly interfaces, and forging strategic partnerships for market expansion and distribution.

However, market growth faces limitations like regulatory challenges, high cost of advanced testing devices, and competition from alternative technologies like continuous glucose monitors. There are also privacy concerns related to data management in digital POCT solutions. Areas poised for innovation include the development of non-invasive testing methods, integration of AI for predictive analytics and real-time monitoring, and improvements in device portability and connectivity. Exploring these avenues can lead to enhanced patient compliance and broader adoption. The market's nature is dynamic yet fragmented, with significant potential for new entrants offering disruptive technologies. Focused R&D and an understanding of regional market dynamics are crucial for sustained business growth in this sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Point-of-Care Glucose Testing Market

The Point-of-Care Glucose Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Increase in the prevalence rate of diabetic patients
- Growing incorporation of data management programs in the monitoring of glucose
- Growing demand for home healthcare from developed and developing countries
Market Restraints
- High cost of product development
Market Opportunities
- Integration of digital technologies for better testing
- Expansion of supply chain and distribution networks
Market Challenges
- Potential interference and calibration issues in glucose meters

Porter's Five Forces: A Strategic Tool for Navigating the Point-of-Care Glucose Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Point-of-Care Glucose Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Point-of-Care Glucose Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Point-of-Care Glucose Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Point-of-Care Glucose Testing Market

A detailed market share analysis in the Point-of-Care Glucose Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Point-of-Care Glucose Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Point-of-Care Glucose Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Point-of-Care Glucose Testing Market

A strategic analysis of the Point-of-Care Glucose Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Point-of-Care Glucose Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accubiotech Co. Ltd., ACON Laboratories, Inc. by Inverness Medical Innovations, Inc., Bio-Rad Laboratories, Danaher Corporation, EKF Diagnostics by IBL PLC, F. Hoffmann-La Roche Ltd., Fluxergy, LifeScan, Inc., Medtronic PLC, Nipro Corporation, Nova Biomedical Corporation, Prodigy Diabetes Care, LLC., Siemens Healthineers AG, and Sinocare.

Market Segmentation & Coverage

This research report categorizes the Point-of-Care Glucose Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Product, market is studied across Accu Check Aviva Meter, Accu-Chek Inform II, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, i-STAT, Onetouch Verio Flex, StatStrip, and True Metrix.
Based on Mode of Purchase, market is studied across OTC Testing Product and Prescription-Based Testing Product.
Based on End-User, market is studied across Home Care Settings, Hospitals & Critical Care Centers, and Outpatient & Ambulatory Care Facilities.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-B9334AD6C44F

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increase in the prevalence rate of diabetic patients
  - 5.1.1.2. Growing incorporation of data management programs in the monitoring of glucose
  - 5.1.1.3. Growing demand for home healthcare from developed and developing countries
- 5.1.2. Restraints
  - 5.1.2.1. High cost of product development
- 5.1.3. Opportunities
  - 5.1.3.1. Integration of digital technologies for better testing
  - 5.1.3.2. Expansion of supply chain and distribution networks
- 5.1.4. Challenges
  - 5.1.4.1. Potential interference and calibration issues in glucose meters
5.2. Market Segmentation Analysis
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Point-of-Care Glucose Testing Market, by Product

6.1. Introduction
6.2. Accu Check Aviva Meter
6.3. Accu-Chek Inform II
6.4. Bayer Contour Blood Glucose Monitoring System
6.5. Freestyle Lite
6.6. i-STAT
6.7. Onetouch Verio Flex
6.8. StatStrip
6.9. True Metrix

7. Point-of-Care Glucose Testing Market, by Mode of Purchase

7.1. Introduction
7.2. OTC Testing Product
7.3. Prescription-Based Testing Product

8. Point-of-Care Glucose Testing Market, by End-User

8.1. Introduction
8.2. Home Care Settings
8.3. Hospitals & Critical Care Centers
8.4. Outpatient & Ambulatory Care Facilities

9. Americas Point-of-Care Glucose Testing Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Point-of-Care Glucose Testing Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Point-of-Care Glucose Testing Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation

Companies Mentioned

1. Abbott Laboratories
2. Accubiotech Co. Ltd.
3. ACON Laboratories, Inc. by Inverness Medical Innovations, Inc.
4. Bio-Rad Laboratories
5. Danaher Corporation
6. EKF Diagnostics by IBL PLC
7. F. Hoffmann-La Roche Ltd.
8. Fluxergy
9. LifeScan, Inc.
10. Medtronic PLC
11. Nipro Corporation
12. Nova Biomedical Corporation
13. Prodigy Diabetes Care, LLC.
14. Siemens Healthineers AG
15. Sinocare